Cases by country, the UK and NHS pathway and other country lenses, the expert centres with trials on record, and the centres named on this cancer's subtypes.
No country-level case numbers. This cancer is not mapped to a GLOBOCAN site.
Southampton · hospital | United Kingdom | none recorded | 0 | 434 | 3,990 | - | |
Leeds · hospital | United Kingdom | none recorded | 0 | 363 | 6,609 | - | |
Vancouver, BC · cancer center | Canada | none recorded | 0 | 305 | 2,733 | - | |
Sendai · hospital | Japan | none recorded | 0 | 161 | 936 | - | |
Reston, VA · consortium | United States | none recorded | 0 | 12 | 108 | - | |
London · consortium | United Kingdom | none recorded | 0 | not matched | - | none recorded | - |
London · consortium | United Kingdom | none recorded | 0 | not matched | - | none recorded | - |
Aylesbury · consortium | United Kingdom | none recorded | 0 | not matched | - | none recorded | - |
These are the things we can measure; they are not a ranking of quality. Each column is a field on the institution record or a count over what OnCo has linked; a centre that treats many patients with Primary cutaneous anaplastic large cell lymphoma but is thinly recorded here will look small.
Not known: OnCo holds no case-volume or outcome figures for centres, so none are shown. Where a national audit or registry publishes them, the centre's page links to it. Default order: Newsweek rank, then trials for this cancer, then research output.